Ultra-Low-Temperature Freezers for COVID-19 Vaccines
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines.
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines. Designed with enhanced robustness, efficiency, and ergonomics, the freezers come equipped with vacuum panels for high levels of insulation to uphold a temperature of -80 ºC with ambient temperatures up to +28 ºC. Instead of using polyurethane foam like many standard freezers, Boreas feature a thinner inner insulation for an enlarged storage capacity of up to 30%. Additionally, the freezers use high purity natural refrigerant CFC free gases that contribute to environment preservation.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
